April 2015

They are bigger than ever. Specialty pharmacy drugs have made their bargaining power more important than ever. Do the P and B in PBM stand for power broker?
Robert Calandra
Formulary exclusions give them added clout with drug companies in this day and age of high-priced medications for conditions that really aren’t so rare.
Thomas Reinke
The man who has shaken up the pharmacy industry isn’t done yet.
Interview by Peter Wehrwein
The failure of the second largest consumer-oriented-and-operated health plan may be a bad omen for the future of other plans. Or maybe not.
Richard Mark Kirkner
Lung cancer is the deadliest cancer, but screening for it has languished. Low-dose CT scans may change that—but what about all those false positives?
Susan Worley


Formulary Files
Krishna Rutvij Patel, PharmD
Legislation & Regulation
What started out as a charitable effort has morphed into a hospital and pharmacy enrichment scheme. Can it be fixed?
Richard Mark Kirkner
Medication Management
The legal challenges are underway, and cost-effectiveness questions will dog these trendsetters at the beginning.
Thomas Reinke
Tomorrow’s Medicine
TissuGlu binds tissue layers together after tummy tucks so fluid that can cause infection doesn’t accumulate and healing improves.
Thomas Morrow, MD